Arie Belldegrun Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Arie Belldegrun.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Arie Belldegrun. Arie Belldegrun is Director in Talon Therapeutics, Inc. ($EMLR) and Director in Arno Therapeutics, Inc ($ARNI) and Director in Cougar Biotechnology, Inc. ($CGRB) and Chairman, President and CEO in Kite Pharma, Inc. ($KITE) and Director in UroGen Pharma Ltd. ($URGN) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON).

Latest Insider Trading Transactions of Arie Belldegrun

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALLO, ARNI, CGRB, KITE, KRON, EMLR, URGN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 23 2021	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	A	24.18	20,600	498,108	20,600
May 25 2021	ALLO	Allogene Therapeut ...	Belldegrun Arie		Option Exercise	M	18.22	379,066	6,906,583	0
May 25 2021	ALLO	Allogene Therapeut ...	Belldegrun Arie		Buy	M	18.22	379,066	6,906,583	583,034	204 K to 583 K (+185.85 %)
Apr 22 2021	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Option Exercise	M	5.00	3,241	16,205	0
Apr 22 2021	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Buy	M	5.00	3,241	16,205	245,452	242.2 K to 245.5 K (+1.34 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	1,304,563	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	650,000	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	228,315	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	173,333	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	1,304,563	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	16.15	253,251	4,090,004	2,315,314	2.1 M to 2.3 M (+12.28 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	650,000	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	1,376,313	0	2,062,063	685.8 K to 2.1 M (+200.70 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	228,315	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	685,750	0	685,750	0 to 685.8 K
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Option Exercise	C	0.00	173,333	0	0
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	240,872	0	679,575	438.7 K to 679.6 K (+54.91 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	16.15	253,251	4,090,004	2,315,314	2.1 M to 2.3 M (+12.28 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	182,866	0	438,703	255.8 K to 438.7 K (+71.48 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	1,376,313	0	2,062,063	685.8 K to 2.1 M (+200.70 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	685,750	0	685,750	0 to 685.8 K
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	240,872	0	679,575	438.7 K to 679.6 K (+54.91 %)
Oct 16 2020	KRON	Kronos Bio, Inc.	Belldegrun Arie	Director	Buy	C	0.00	182,866	0	438,703	255.8 K to 438.7 K (+71.48 %)
Jun 10 2020	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Option Exercise	A	28.24	10,000	282,400	10,000
Jun 04 2020	ALLO	Allogene Therapeut ...	Belldegrun Arie		Buy	P	47.00	106,382	4,999,954	1,798,163	1.7 M to 1.8 M (+6.29 %)
Jun 04 2020	ALLO	Allogene Therapeut ...	Belldegrun Arie		Buy	P	47.00	40,000	1,880,000	40,000	0 to 40 K
Mar 20 2020	ALLO	Allogene Therapeut ...	Belldegrun Arie		Option Exercise	A	18.22	379,066	6,906,583	379,066
Jun 05 2019	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Option Exercise	A	34.83	10,000	348,300	10,000
Jun 05 2019	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Option Exercise	A	34.83	10,000	348,300	10,000
May 15 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	J	0.00	13,413	0	515,076	501.7 K to 515.1 K (+2.67 %)
May 15 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Sell	J	0.00	598,935	0	4,791,480	5.4 M to 4.8 M (-11.11 %)
Apr 30 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	J	0.00	13,413	0	501,663	488.3 K to 501.7 K (+2.75 %)
Apr 30 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Sell	J	0.00	598,937	0	5,390,415	6 M to 5.4 M (-10.00 %)
Mar 28 2019	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Option Exercise	M	4.02	128,000	514,560	0
Mar 28 2019	URGN	UroGen Pharma Ltd.	Belldegrun Arie	Director	Buy	M	4.02	128,000	514,560	212,211	84.2 K to 212.2 K (+152.00 %)
Mar 15 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Option Exercise	A	26.89	195,133	5,247,126	195,133
Mar 15 2019	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Grant	A	0.00	115,333	0	150,333	35 K to 150.3 K (+329.52 %)
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Option Exercise	C	0.00	285,207	0	0
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Option Exercise	C	0.00	1,140,829	0	0
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Option Exercise	C	0.00	27,095	0	0
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	C	0.00	1,497,336	0	1,497,336	0 to 1.5 M
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	C	0.00	5,989,352	0	5,989,352	0 to 6 M
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	C	0.00	142,248	0	3,710,006	3.6 M to 3.7 M (+3.99 %)
Oct 17 2018	ALLO	Allogene Therapeut ...	Belldegrun Arie	Director	Buy	P	18.00	35,000	630,000	35,000	0 to 35 K
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	D	47.42	159,700	7,572,974	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	D	63.87	56,643	3,617,788	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	D	63.87	44,057	2,813,921	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	D	51.96	43,500	2,260,260	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	D	51.96	95,700	4,972,572	0
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	180.00	500,000	90,000,000	0	500 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	180.00	500,000	90,000,000	0	500 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	180.00	430,190	77,434,200	0	430.2 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	180.00	159,329	28,679,220	0	159.3 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	180.00	1,607,750	289,395,000	0	1.6 M to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	D	0.00	159,160	0	0	159.2 K to 0 (-100.00 %)
Oct 05 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	50,000	0	159,160	109.2 K to 159.2 K (+45.80 %)
Sep 27 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	S	179.66	26,347	4,733,605	109,160	135.5 K to 109.2 K (-19.44 %)
Sep 27 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	50,000	0	135,507	85.5 K to 135.5 K (+58.47 %)
May 09 2017	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Buy	P	68.57	17,000	1,165,690	85,507	68.5 K to 85.5 K (+24.81 %)
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	A	47.72	159,700	7,620,884	159,700
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	43,800	0	68,507	24.7 K to 68.5 K (+177.28 %)
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Gift	G	0.00	66,000	0	1,607,750	1.7 M to 1.6 M (-3.94 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	S	50.86	3,493	177,654	24,707	28.2 K to 24.7 K (-12.39 %)
Aug 17 2016	ARNI	Arno Therapeutics, ...	Belldegrun Arie	Director	Option Exercise	P	0.44	357,142	156,250	357,142
Aug 17 2016	ARNI	Arno Therapeutics, ...	Belldegrun Arie	Director	Buy	P	0.00	714,285	0	2,262,838	1.5 M to 2.3 M (+46.13 %)
Apr 11 2016	ARNI	Arno Therapeutics, ...	Belldegrun Arie	Director	Option Exercise	A	0.37	177,256	65,585	177,256
Jan 14 2016	ARNI	Arno Therapeutics, ...	Belldegrun Arie	Director	Buy	P	0.35	714,285	250,000	858,094	143.8 K to 858.1 K (+496.69 %)
Jan 14 2016	ARNI	Arno Therapeutics, ...	Belldegrun Arie	Director	Buy	P	0.35	1,448,062	506,822	1,548,543	100.5 K to 1.5 M (+1,441.13 %)
Dec 21 2015	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	A	63.87	100,700	6,431,709	100,700
Dec 21 2015	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	28,200	0	28,200	0 to 28.2 K
Mar 03 2008	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	27.00	4,700	126,900	64,664	60 K to 64.7 K (+7.84 %)
Mar 03 2008	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	26.99	300	8,097	59,964	59.7 K to 60 K (+0.50 %)
Dec 18 2007	EMLR	Talon Therapeutics ...	Belldegrun Arie	Director	Option Exercise	A	1.12	40,000	44,800	40,000
Dec 20 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	30.50	15,000	457,500	59,664	44.7 K to 59.7 K (+33.58 %)
Jun 19 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	23.90	3,700	88,430	44,664	41 K to 44.7 K (+9.03 %)
Jun 13 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Option Exercise	A	24.50	10,000	245,000	10,000
May 10 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	21.10	7,100	149,810	40,964	33.9 K to 41 K (+20.97 %)
Mar 09 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	18.55	1,000	18,550	33,864	32.9 K to 33.9 K (+3.04 %)
Mar 09 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	18.85	500	9,425	32,864	32.4 K to 32.9 K (+1.54 %)
Mar 09 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	18.40	5,500	101,200	32,364	26.9 K to 32.4 K (+20.47 %)
Mar 09 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	18.30	4,000	73,200	26,864	22.9 K to 26.9 K (+17.49 %)
Mar 09 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Buy	P	18.15	4,000	72,600	22,864	18.9 K to 22.9 K (+21.20 %)
Jan 10 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Option Exercise	A	2.60	38,411	99,869	38,411
Jan 10 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Option Exercise	D	0.39	38,411	14,999	38,411
Jan 10 2007	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Grant	A	0.00	18,864	0	18,864	0 to 18.9 K
Dec 18 2006	EMLR	Talon Therapeutics ...	Belldegrun Arie	Director	Option Exercise	A	6.82	40,000	272,800	40,000
Sep 11 2006	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Option Exercise	A	4.50	200,000	900,000	200,000
Sep 11 2006	CGRB	Cougar Biotechnolo ...	Belldegrun Arie	Director	Option Exercise	A	4.50	30,000	135,000	30,000
Nov 15 2005	EMLR	Talon Therapeutics ...	Belldegrun Arie	Director	Option Exercise	A	4.75	40,000	190,000	40,000
Jul 18 2005	EMLR	Talon Therapeutics ...	Belldegrun Arie	Director	Option Exercise	A	1.65	20,000	33,000	20,000
Jul 18 2005	EMLR	Talon Therapeutics ...	Belldegrun Arie	Director	Option Exercise	A	1.33	20,000	26,600	20,000

Page: 1